Manuel Ploch brings to ICON over 18 years of operational experience in the Japanese pharmaceutical R&D market. Prior...
Manuel Ploch brings to ICON over 18 years of operational experience in the Japanese pharmaceutical R&D market. Prior...
David joins Atlas from DNA Electronics, where he worked as Manufacturing & Mechanical Engineering Manager, responsible...
Prior to his current position, Richard was VP Global Commercial leader in the global Rare Disease Unit
Mike brings with him extensive experience in psychometrics and in the development and validation of quality of life...
Evans is an experienced and respected Client Services Director who is well known by clients and candidates across the...
Knowles succeeds Nicholas Cross who has been Chairman since the company was founded in 2008 and will remain on the...
McGrath is the current president, chief financial officer and a member of the Board of Directors of PhotoMedex, a...
Mr Webster is currently the chief executive of Leeds Community Healthcare NHS Trust (LCHT), an innovative NHS trust...
Marschner recently joined Affimed from Merck KGaA. He has 18 years of professional experience in clinical development...
He joins at a time when the Company is progressing fast towards the filing for approval of its lead product for the...
David has more than 20 years' experience in the global healthcare industry, working for companies such as Quintiles.
David Evans has stepped down as Chairman of the Board.
Jane joins from Chugai Pharma UK Ltd where she was Commercial Manager for 7 years, prior to which 8 years of wholesale...
Sieler is a former Chairman and CEO of Bayer France.
Dr Chris Dunk has been appointed Director of Clinical Development, Simon Kerr Director of Business Development, and...